Any current/future new fundraising through debt or equity?

There is no indication of any current or future fundraising through debt or equity mentioned. A temporary borrowing of Rs. 50 crores happened in the March quarter as working capital inflow, which has since been repaid. The company is now debt-free, with practically zero net debt (about Rs. 8 lakhs). There is no discussion or mention of any plans for raising equity capital. The management appears focused on maintaining sustainable growth and margin improvement without increasing debt levels substantially.

Future growth expectations in sales/revenue/volumes?

The company expects consistent double-digit growth in revenue over the next few years, driven by normalization in demand and improved macroeconomic conditions. Food and nutrition portfolio is anticipated to grow in double digits, recovering from previous seasonal and external impacts. Personal care categories have shown resilient double-digit growth and are expected to continue this trend. Sweetener portfolio (Sugar Free Green and I'm lite) is witnessing revival and is expected to enhance growth further. Expansion plans include increasing distribution touchpoints from 3 million to 3.5 million

Future growth expectations in earnings/operating earnings/profits/EPS?

The company aims for consistent double-digit revenue growth over the next few years, supported by stable macroeconomic conditions and operational improvements. Food and nutrition portfolio is expected to rebound with double-digit growth, driven by brands like Glucon-D, Complan, and sweeteners (Sugar Free Green, I'm lite). Personal care categories continue to show strong double-digit growth, aiding overall revenue expansion. EBITDA margin target is ambitious at 17%-18% over the next 2 years, driven by gross margin improvement and operating leverage. Advertisement and brand-building investments

Zydus WellnessQ4 FY24Food Products

Zydus Wellness Q4 FY24 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹493P/E: 74.8Market Cap: ₹16.6K CrSector: Food Products

Management growth scorecard

Revenue

Category 3

Margin

Category 1

Fundraise

N/A

Order

N/A

Capex

N/A

1 of 2 growth signals are positive — mixed outlook.

Full analysis

Revenue guidance

Category 3

The company expects consistent double-digit growth in revenue over the next few years, driven by normalization in demand and improved macroeconomic conditions.
Food and nutrition portfolio is anticipated to grow in double digits, recovering from previous seasonal and external impacts.
Personal care categories have shown resilient double-digit growth and are expected to continue this trend.
Sweetener portfolio (Sugar Free Green and I'm lite) is witnessing revival and is expected to enhance growth further.
Expansion plans include increasing distribution touchpoints from 3 million to 3.5 million outlets over the next two years.
International markets like GCC and India subcontinent are poised for significant double-digit growth, despite challenges in markets like Nigeria.
Category-specific revival noted: Glucon-D expected to return to growth post-Covid disruption; Complan's nutritional drink category shows a gradual revival.
Overall optimism on sustaining and enhancing growth supported by increased marketing investments and supply chain improvements.

Margin guidance

Category 1

The company aims for consistent double-digit revenue growth over the next few years, supported by stable macroeconomic conditions and operational improvements.
Food and nutrition portfolio is expected to rebound with double-digit growth, driven by brands like Glucon-D, Complan, and sweeteners (Sugar Free Green, I'm lite).
Personal care categories continue to show strong double-digit growth, aiding overall revenue expansion.
EBITDA margin target is ambitious at 17%-18% over the next 2 years, driven by gross margin improvement and operating leverage.
Advertisement and brand-building investments have increased to support demand and competitive positioning but expected to stabilize around 13%-14% of expenses.
International business growth, especially in GCC, India subcontinent, and Africa, could double revenue share to 7%-8% in coming years, enhancing profitability.
Management balances margin expansion with sustainable investment for long-term growth, implying gradual improvement in operating earnings and EPS.

See what Zydus Wellness management said on margin guidance — free account, 30 seconds.

Fundraise plans

There is no indication of any current or future fundraising through debt or equity mentioned.
A temporary borrowing of Rs. 50 crores happened in the March quarter as working capital inflow, which has since been repaid.
The company is now debt-free, with practically zero net debt (about Rs. 8 lakhs).
There is no discussion or mention of any plans for raising equity capital.
The management appears focused on maintaining sustainable growth and margin improvement without increasing debt levels substantially.

Order book

The transcript of Zydus Wellness Limited's Q4 FY24 Earnings Call does not provide any specific information regarding the current or expected order book or pending orders. The discussion primarily focuses on: - Growth prospects across categories (personal care, food, nutrition). - Distribution expansion plans (from 3.0 to 3.5 million outlets). - Market share and category growth (e.g., Complan, Sugar Free). - Margin improvement and expense management. - International business and geographic focus. - Marketing investments and competition. - No direct mention of order book or backlog details. Thus, there is no disclosed data on current or expected order book or pending orders in the available transcript.

See what Zydus Wellness management said on order book — free account, 30 seconds.

Capex plans

The transcript does not explicitly mention any specific current or future capex, capital investment, or strategic investment plans. However, some relevant points include: - Focus on expanding distribution within existing markets (increasing reach from 3 million to 3.5 million outlets over the next two years). - Investments in brand-building activities, with advertising and A&P spend increased for demand generation and competition management. - Introduction of a hub-and-spoke model to strengthen supply chain capabilities and improve product availability in key markets. - No mention of substantial increase in overall expenses or investments; the management aims to keep expense ratio around 13%-14%. - Margin expansion goals suggest some investment into operating leverage and cost management but no large-scale capex outlined. Overall, strategic investments seem focused on distribution expansion, brand marketing, and supply chain optimization rather than large capex projects.

Track Zydus Wellness — get its next earnings analysis in your feed

How does Zydus Wellness rank vs peers in Food Products?

Pro feature

ThisZydus Wellness

Rev 3Mar 1

See where Zydus Wellness sits in Food ProductsSee which companies these are, and every other name in the sector.Open rankings

How does Zydus Wellness rank in Food Products?

Compare Zydus Wellness against every Food Products company (Q4 FY24) on revenue, margins and earnings-call signals.

View Food Products leaderboard →

What Zydus Wellness's management said in earlier quarters

Others in Food Products this season

Sheetal Cool Products Ltd (Q1 FY27)
Revenue from Operations for FY26: ₹366.0 Crores, up 13.9% YoY from ₹321.3 Crores in FY25 (Page 29, 5). Key investor presentation takeaways from Sheetal Cool Pro
Mukka Proteins Ltd (Q4 FY26)
Q4 FY26 Revenue from Operations:** ₹381.6 Cr . Key concall takeaways from Mukka Proteins Ltd's Q4 FY26 earnings call — and how it ranks against sector peers.
Mukka Proteins Ltd (Q1 FY27)
Q1 FY27 Revenue from Operations: ₹489.7 crore . Key concall takeaways from Mukka Proteins Ltd's Q1 FY27 earnings call — and how it ranks against sector peers.
Shri Ahimsa Naturals Ltd (Q4 FY26)
Revenue figures (₹ in Crs) for FY: . Key concall takeaways from Shri Ahimsa Naturals Ltd's Q4 FY26 earnings call — and how it ranks against sector peers.

Compare:vs Nestle India vs Britannia Inds.vs Hatsun Agro Product Ltd

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →